Xiao Xiao-Yi 4
4 · TETRAPHASE PHARMACEUTICALS INC · Filed Mar 27, 2013
Insider Transaction Report
Form 4
Xiao Xiao-Yi
10% Owner
Transactions
- Conversion
Common Stock
2013-03-25+413→ 9,033 total - Conversion
Series B Convertible
2013-03-25−12,000→ 0 total→ Common Stock (413 underlying)
Footnotes (2)
- [F1]The Series A-1, Series A-2, Series B and Series C Convertible Preferred Stock converted into Common Stock on a 1-for-29 basis upon the closing of the issuer's initial public offering without payment of consideration.
- [F2]Not Applicable